As Executive Vice President and Worldwide Chairman of MedTech at Johnson & Johnson, Tim Schmid is transforming the future of healthcare. Under Tim’s leadership, the $30B organization of 75,000+ employees is focused on developing and delivering medical technologies that help save lives, change the course of disease, and restore health.
With a presence in nearly every operating room in the world and touching more than 300 million patients annually, Johnson & Johnson MedTech is comprised of twelve $1B platforms across orthopaedics, surgery, cardiovascular, and vision. Together, these businesses are developing smarter, less invasive, and more personalized solutions to address the world’s most complex diseases.
Tim has been with Johnson & Johnson for more than 30 years and has served in leadership positions spanning numerous multi-billion-dollar businesses on three continents. Most recently, he was Company Group Chairman, Johnson & Johnson MedTech Asia Pacific, where he led the company’s efforts to bring life changing medical technology to patients and become the company’s fastest growing region. Tim has also served as Chief Strategic Customer Officer and President of Ethicon.
Tim is a global healthcare leader and a proven architect of winning teams, delivering above-market performance, leading business transformations and driving innovation across the medical technology industry. He is a champion of diversity and a strong advocate for supporting the communities and partners we serve. He was instrumental in establishing Johnson & Johnson’s global partnership with Operation Smile, focused on bringing safe and effective surgical care to children suffering from cleft lip or cleft palate.
Educated in South Africa, Canada, and the United Kingdom, Tim has lived and worked in six countries. Tim earned his undergraduate degree from the University of Western Ontario in Canada, and an MBA from Richmond University in the United Kingdom.
What is Timothy Schmid's net worth?
The estimated net worth of Timothy Schmid is at least $2.43 million as of February 18th, 2025. Mr. Schmid owns 15,098 shares of Johnson & Johnson stock worth more than $2,432,892 as of March 25th. This net worth approximation does not reflect any other investments that Mr. Schmid may own. Learn More about Timothy Schmid's net worth.
How do I contact Timothy Schmid?
The corporate mailing address for Mr. Schmid and other Johnson & Johnson executives is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. Johnson & Johnson can also be reached via phone at (732) 524-0400 and via email at investor-relations@its.jnj.com. Learn More on Timothy Schmid's contact information.
Has Timothy Schmid been buying or selling shares of Johnson & Johnson?
In the last ninety days, Timothy Schmid has sold $62,928.45 in shares of Johnson & Johnson stock. Most recently, Timothy Schmid sold 403 shares of the business's stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $156.15, for a transaction totalling $62,928.45. Following the completion of the sale, the executive vice president now directly owns 15,098 shares of the company's stock, valued at $2,357,552.70. Learn More on Timothy Schmid's trading history.
Who are Johnson & Johnson's active insiders?
Johnson & Johnson's insider roster includes Dominic Caruso (VP), Robert Decker (CAO), Joaquin Duato (CEO & Chairman), Peter Fasolo (VP), Alex Gorsky (CEO), William Hait (Insider), Ronald Kapusta (CAO), Ashley McEvoy (EVP), Thibaut Mongon (VP), William Perez (Director), Timothy Schmid (EVP, Worldwide Chairman, MedTech), Michael Sneed (COO), Paulus Stoffels (VP), James Swanson (EVP), Jennifer Taubert (EVP), Mark Weinberger (Director), Kathryn Wengel (EVP), Joseph Wolk (CFO), and Joseph Wolk (Exec. VP & CFO ). Learn More on Johnson & Johnson's active insiders.
Are insiders buying or selling shares of Johnson & Johnson?
During the last year, Johnson & Johnson insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $147,220.00. During the last year, insiders at the sold shares 3 times. They sold a total of 13,037 shares worth more than $2,154,035.67. The most recent insider tranaction occured on February, 25th when VP Robert J Decker sold 6,999 shares worth more than $1,160,994.12. Insiders at Johnson & Johnson own 0.2% of the company.
Learn More about insider trades at Johnson & Johnson. Information on this page was last updated on 2/25/2025.
